have posted since I started this blog. There is TONS OF
INFORMATION there for you to learn from. It's the type
of information that not only saved my life...It also has
given me a better quality of life.
Why Arthritis Drugs Don't Work and the
Natural Method That Does.
The Solution For Disease FREE Health...
Why High Blood Pressure Drugs Don't Work And
The Natural Method That Does
World's #1 Publisher of Information About Alternative
Cancer Treatments Cancer Defeated
Continued from 1-27-14
It’s Starting to Look Like a Coordinated Yet Cleverly Designed PR Campaign...
When looking at a number of different yet related events, this
whole thing is starting to look like a well-coordinated PR push where
a number of companies and industries stand to gain. The only real
loser in this game appears to be women in general... First, as we
predicted would happen months ago, the Supreme Court ruled in favor of
Monsanto in the Monsanto vs. Bowman case, thereby affirming that a
patent holder can control the use of its patent through multiple
generations of seed. Alas, the implications of this ruling go far
beyond agriculture. It will also have implications for other businesses
such as vaccines, cell lines, and human genes.
What this ruling does is grant ownership of genetic material in
perpetuity. A silly but simple analogy would be that if you own the
patent to a dog trait, and your dog with that trait impregnates all
the neighbors’ dogs, all the pups would be yours, as would the pups
of those pups, and so on. As we predicted, the Supreme Court only
took this case to protect the biotech industry by setting precedent.
There is very little morality left in our fascist federal government,
and that includes most of its agencies, including the IRS, FDA, and
FTC. They’re all operating for political and industrial gains.
In Monsanto vs. Bowman, Justice Kagan justified the unanimous
decision to allow living, self-replicating organisms and their off
-spring to be licensed property of the patent owner due to financial
interests. A patent would plummet in value after the first sale of
the item containing the invention, she said. And just seconds into
Bowman’s attorney’s opening arguments, Chief Justice Roberts
interrupted him by asking why anyone would ever patent anything if
Bowman were to prevail?
That and more indicated that it was a closed case right from
the start...Justice Breyer went so far as referencing the infamous
law Buck vs Bell (that still stands in the US to this day, which
legitimizes government-forced sterilization and vaccination) when
he said: There are three generations of seeds. Maybe three
generations of seeds is enough. This was a spin on Supreme Court
Justice Oliver Wendell Holmes's statement:
"It is better for all the world if, instead of waiting to
execute degenerate offspring for crime or to let them starve for
their imbecility, society can prevent those who are manifestly
unfit from continuing their kind. The principle that sustains
compulsory vaccination is broad enough to cover cutting the
Fallopian tubes. Three generations of imbeciles are enough."
It’s a chilling thought when you consider the potential
implications this case can have on the trend of patenting of
human genes and other life forms. Over 20% of the human genome
is already patented, and the old eugenics movement has a lot
in common with the burgeoning anti-choice movement when it comes
to vaccinations and other medical treatments, including cancer
treatment for minors. Children have been taken from their parents
for refusing to follow the conventional cut-poison-burn cancer
treatment plan for their ailing children, even though statistics
and research clearly shows that chemotherapy is typically what
ends up killing the patient, even when the cancer itself is
GMO Opponents Are 'Elitist' and Insensitive to World’s Needs,
Monsanto CEO Says
If the idea of a new eugenics movement is not enough, Monsanto
CEO Hugh Grant was recently quoted stating that opponents who want
to block genetically modified foods are guilty of “elitism” and fail
to consider the needs of the rest of the world. Thank goodness the
CEO of a $58 billion multinational corporation, which last year paid
him over $14 million, is ready to stand up to the selfish elitists
opposing his plan to save the world...
But I digress... On May 14, one day after Big Biotech was granted
patent rights to genetic material in perpetuity, Angelina Jolie’s op-ed
comes out, and the very next day, biotech stocks took a jump. Then
on the 16th, Arthur Caplan, director of the Division of Bioethics at
New York University's Langone Medical Center, pens a CNN op-ed
applauding Jolie’s brave message. Chillingly, he ends his article
As the U.S. pushes forward into health reform, Jolie's story
reminds us that we need to adjust our health care system from one that
pays for treatment to one that also covers prevention.
Prevention here meaning a $4000 test that if positive results in
amputation of a non-diseased organ... According to reports,18 Jolie
is also planning to remove her ovaries to limit her risk of ovarian
cancer—a decision that leads to ‘surgical menopause,’ which requires
careful hormone replacement and monitoring.
Truly, we need to drive home the message that testing is NOT
prevention. Testing is a diagnostic tool that has nothing to do
with actually preventing disease. True prevention requires taking a
close hard look at lifestyle choices, as well as making some radical
changes to a wide range of industries that don’t want to change the
way they do business. Toxic chemicals are oftentimes far cheaper
to use than all-natural ones. And toxins drive cancer processes
in your body...
The Angelina Effect—Don’t Be Swayed...
Deception by the agricultural, food, biotech, chemical, and
personal care product industries are primary drivers of most of
the chronic and deadly diseases plaguing our modern society. They’re
poisoning you from all angles, and then pretend to have the solutions...
Parallel with this mockery of a science-based health care system,
federal agencies have been cleverly manipulated by highly leveraged
lobbying to force you to pay for most of this by tax subsides, and
federal regulatory agencies limiting your choices.
Within days of her coming out, Jolie again graced the cover of
TIME magazine with the words: The Angelina Effect Angelina Jolie’s
double mastectomy puts genetic testing in the spotlight. What her
choice reveals about calculating risk, cost, and peace of mind.
I have no special insights about what this woman has been thinking,
but I certainly don’t blame her. To me she is merely a victim of
sophisticated and clever techniques that have successfully twisted
common sense on its head. She has learned to trust and believe in the
system that has created this insanity. The PR campaign that catalyzed
her decision is clearly aimed at deceiving naïve and preoccupied people
into an utterly flawed system motivated primarily by corporate greed
not by any compassion or desire to decrease human suffering.
I don’t fault Jolie for any of it. She, like everyone else, made
the best decision she could based on the information she was given or
sought out. Few people have enough time to study and understand the
complexity of system that has evolved for over a century.
In this case, the goal is not to empower you to make proactive
decisions about your health. It’s about herding you into the fold
of the most profitable industries in the world. Myriad Genetics alone
rakes in approximately half a billion dollars in revenue each year.
Genetic testing for breast cancer accounts for 85 percent of their
total revenue, and again, they have complete and total control of
this niche since they own the patent for the BRCA genes. Salon magazine
recently wrote an article titled "How One Company Controls Your Breast
Myriad’s monopoly over BRCA1 and BRCA2 not only means showing
that it can charge whatever it wants for the test; it also means that
further research on the genes is restricted, and that women who take
the test and get an ambiguous result can’t get a second opinion, only
take the test again. An ambiguous result can mean the difference
between removing breasts or ovaries or leaving them intact.
The economic and racial implications of all this are major,
both for how the research has been done and who gets access to it. In a
video on the case, the ACLU points out, 'Initial gene studies focused
on white women. And now the patents make it more difficult to learn
what some mutations mean in women of color, because Myriad has total
control over researchers’ access to those mutations....Myriad’s patent
on the genes expires in two years, but the Supreme Court’s ruling will
set the broader principle going forward. For now, Jolie’s Op-Ed has
apparently made Myriad’s stock price rise 4 percent, its best level in
God Bless Everyone & God Bless The United States of America.
42 S. Sherwood Dr.
Belton, Tx. 76513